01.06.2022 08:18 | ONC | Holding(s) in Company | RNS |
31.05.2022 12:41 | ONC | Holding(s) in Company | RNS |
26.05.2022 09:57 | ONC | Holding(s) in Company | RNS |
23.05.2022 16:27 | ONC | Holding(s) in Company | RNS |
20.05.2022 12:11 | ONC | Holding(s) in Company | RNS |
18.05.2022 11:46 | ONC | Holding(s) in Company | RNS |
05.05.2022 17:32 | ONC | Holding(s) in Company | RNS |
03.05.2022 18:10 | ONC | Holding(s) in Company | RNS |
26.04.2022 16:26 | ONC | Holding(s) in Company | RNS |
21.04.2022 07:00 | ONC | Queen’s Award for Enterprise in Innovation 2022 | Reach |
14.04.2022 12:24 | ONC | Exercise of Options, PDMR Dealing and TVR | RNS |
08.04.2022 10:54 | ONC | IN BRIEF: Oncimmune shares lifted on two new US contract wins | Alliance |
08.04.2022 07:00 | ONC | Two further ImmunoINSIGHTS contracts signed | RNS |
04.04.2022 14:43 | ONC | Holding(s) in Company | RNS |
29.03.2022 16:46 | ONC | Exercise of Options, PDMR Dealing and TVR | RNS |
18.03.2022 15:01 | ONC | Holding(s) in Company | RNS |
16.03.2022 07:00 | ONC | Block Listing Six Monthly Return | RNS |
15.03.2022 07:00 | ONC | Exercise of Warrants and Total Voting Rights | RNS |
09.03.2022 16:08 | ONC | Holding(s) in Company | RNS |
07.03.2022 21:38 | ONC | IN BRIEF: Oncimmune signs follow-on Covid autoimmunity contract | Alliance |
07.03.2022 14:10 | ONC | PDMR Dealing | RNS |
07.03.2022 07:00 | ONC | Follow-on contract to validate previous profiling | RNS |
04.03.2022 20:53 | AGY, SEED, ONC | TRADING UPDATES: IOG to cut Gazprom ties; wholesale changes at Donegal | Alliance |
04.03.2022 07:00 | ONC | ImmunoINSIGHTS contract signed with global pharma | RNS |
01.03.2022 07:00 | ONC | ImmunoINSIGHTS and Synexa partnership | RNS |
28.02.2022 19:41 | MTEC, DATA, ONC | TRADING UPDATES: Profit rise for GlobalData, Greencoat keeps dividend | Alliance |
28.02.2022 07:05 | ONC | Interim Results | RNS |
28.02.2022 07:00 | ONC | Contract signed with Verily Life Sciences | RNS |
25.02.2022 07:00 | ONC | Notice of Half Year Results | RNS |
21.02.2022 15:14 | ONC | Holding(s) in Company | RNS |
17.02.2022 07:00 | ONC | EarlyCDT Lung approved and adopted in Aragon Spain | Reach |
15.02.2022 07:00 | ONC | ImmunoINSIGHTS commercial update | RNS |
31.12.2021 07:00 | ONC | Results from COVID-19 autoantibody profiling panel | RNS |
24.12.2021 07:00 | ONC | PDMR Dealing | RNS |
22.12.2021 11:10 | ONC | Grant of Options and PDMR Dealing | RNS |
21.12.2021 11:34 | ONC | PDMR Dealing | RNS |
21.12.2021 07:00 | ONC | ImmunoINSIGHTS commercial update | RNS |
20.12.2021 15:13 | ONC | Total Voting Rights | RNS |
07.12.2021 07:00 | ONC | Commercial momentum in ImmunoINSIGHTS | RNS |
26.11.2021 16:41 | ONC | Second Price Monitoring Extn | RNS |
26.11.2021 16:36 | ONC | Price Monitoring Extension | RNS |
26.11.2021 10:36 | ONC | Results of Annual General Meeting | RNS |
03.11.2021 07:00 | ONC | Notice of AGM and posting of Annual Report | RNS |
02.11.2021 07:00 | ONC | Full year results and progress update | RNS |
02.11.2021 07:00 | ONC | Change of Adviser | RNS |
27.10.2021 16:35 | ONC | Price Monitoring Extension | RNS |
25.10.2021 16:40 | ONC | Second Price Monitoring Extn | RNS |
25.10.2021 16:35 | ONC | Price Monitoring Extension | RNS |
25.10.2021 07:00 | ONC | Notice of Full Year results | RNS |
20.09.2021 07:00 | ONC | Agreement with pharma company to profile patients | RNS |
15.09.2021 11:08 | ONC | Block Listing Six Monthly Return | RNS |
23.08.2021 07:00 | ONC | Three-year follow-up data for the ECLS trial | RNS |
23.07.2021 07:00 | ONC | Agreement signed with major cancer center | RNS |
22.07.2021 07:00 | ONC | Validation of ImmunoINSIGHTS service in COVID-19 | RNS |
08.06.2021 07:00 | ONC | Full Year Trading Update | RNS |
28.05.2021 07:30 | ONC | Notice of FY21 Trading Update | RNS |
05.05.2021 07:03 | ONC | Return of China Rights to EarlyCDT | RNS |
04.05.2021 12:23 | ONC | Total Voting Rights | RNS |
08.04.2021 07:00 | ONC | Holding(s) in Company | RNS |
07.04.2021 14:05 | ONC | Second Price Monitoring Extn | RNS |
07.04.2021 14:00 | ONC | Price Monitoring Extension | RNS |
06.04.2021 13:48 | ONC | Block Listing Six Monthly Return | RNS |
06.04.2021 07:00 | ONC | Holding(s) in Company | RNS |
06.04.2021 07:00 | ONC | Agreements signed with Roche and Cedars-Sinai | RNS |
01.04.2021 07:00 | ONC | Holding(s) in Company | RNS |
25.03.2021 14:01 | ONC | Result of Oversubscribed Equity Placing | RNS |
25.03.2021 07:45 | ONC | Launch of Equity Placing via Accelerated Bookbuild | RNS |
15.03.2021 07:00 | ONC | Issue of Equity and Total Voting Rights | RNS |
01.03.2021 07:00 | ONC | Total Voting Rights | RNS |
15.02.2021 07:00 | ONC | Interim Results | RNS |
25.01.2021 07:00 | ONC | Notice of Half Year Results | RNS |
19.01.2021 16:17 | ONC | Directorate Change | RNS |
18.01.2021 11:37 | ONC | Holding(s) in Company | RNS |
14.01.2021 09:49 | ONC | PDMR Dealing | RNS |
06.01.2021 10:27 | ONC | Total Voting Rights | RNS |